| 000 | 018130000a22003730004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223025947.0 | ||
| 008 | 061207s2005 ua f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.03.Ph.D.2005.Am.A. | ||
| 100 | 0 | _aAmina Mohamed Talat Elnaggar | |
| 245 | 1 | 0 |
_aAssessment of multidrug resistance associated P - glycoprotein and BCL - 2 in chronic lymphocytic leukemia / _cAmina Mohamed Talat Elnaggar ; Supervised Amira Mokhtar Khorshed , Samah Ali Mostafa , Thoraya Mohamed Abd El hamid |
| 246 | 1 | 5 | _aتقدير مقاومة العديد من الادوية المصاحبة للجليكوبروتين (ب) وب س ل - 2 فى حالات سرطان الدم الليمفاوى المزمن |
| 260 |
_aCairo : _bAmina Mohamed Talat Elnaggar , _c2005 |
||
| 300 |
_a159p ; _c25cm |
||
| 502 | _aThesis (PH.D.) - Cairo University - National Cancer Institute - Department Of Clinical Pathology | ||
| 520 | _aA major problem in the treatment of leukemia and lymphoma is caused by the development of drug resistance to chemotherapeutic agents at diagnosis or after chemotherapy induced by drug - resistance proteins such as P - glycoprotein , which work as a drug efflux pump and has antiapoptotic action | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBcl - 2 | |
| 653 | 4 | _aChronic lymphocytic leukemia | |
| 653 | 4 | _aFCM and ICC | |
| 653 | 4 | _aMultidrug resistance | |
| 653 | 4 | _aP.glycoprotein | |
| 700 | 0 |
_aAmira Mokhtar Khorshed , _eSupervisor |
|
| 700 | 0 |
_aSamah Ali Mostafa , _eSupervisor |
|
| 700 | 0 |
_aThoraya Mohamed Abd El hamid , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aEsam _eRevisor |
||
| 905 |
_aMaher _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c24412 _d24412 |
||